about
Increasing awareness of sex differences in airway diseasesA quantitative proteomic approach to identify significantly altered protein networks in the serum of patients with lymphangioleiomyomatosis (LAM).Gender differences in outcomes of patients with cystic fibrosisEvidence Supporting a Lymphatic Endothelium Origin for Angiomyolipoma, a TSC2(-) Tumor Related to Lymphangioleiomyomatosis.Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases.The next breakthrough in LAM clinical trials may be their design: challenges in design and execution of future LAM clinical trials.
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Optimizing treatments for lymphangioleiomyomatosis
@ast
Optimizing treatments for lymphangioleiomyomatosis
@en
Optimizing treatments for lymphangioleiomyomatosis
@nl
type
label
Optimizing treatments for lymphangioleiomyomatosis
@ast
Optimizing treatments for lymphangioleiomyomatosis
@en
Optimizing treatments for lymphangioleiomyomatosis
@nl
prefLabel
Optimizing treatments for lymphangioleiomyomatosis
@ast
Optimizing treatments for lymphangioleiomyomatosis
@en
Optimizing treatments for lymphangioleiomyomatosis
@nl
P2860
P356
P1476
Optimizing treatments for lymphangioleiomyomatosis
@en
P2093
Angelo M Taveira-DaSilva
P2860
P304
P356
10.1586/ERS.12.26
P407
P50
P577
2012-06-01T00:00:00Z